263 related articles for article (PubMed ID: 21357791)
1. Impact of comorbidity on survival among men with localized prostate cancer.
Albertsen PC; Moore DF; Shih W; Lin Y; Li H; Lu-Yao GL
J Clin Oncol; 2011 Apr; 29(10):1335-41. PubMed ID: 21357791
[TBL] [Abstract][Full Text] [Related]
2. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.
Lu-Yao GL; Albertsen PC; Moore DF; Lin Y; DiPaola RS; Yao SL
Eur Urol; 2015 Nov; 68(5):805-11. PubMed ID: 25800944
[TBL] [Abstract][Full Text] [Related]
3. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
Howlader N; Mariotto AB; Woloshin S; Schwartz LM
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):255-64. PubMed ID: 25417239
[TBL] [Abstract][Full Text] [Related]
4. Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool.
Frendl DM; FitzGerald G; Epstein MM; Allison JJ; Sokoloff MH; Ware JE
PLoS One; 2020; 15(12):e0240039. PubMed ID: 33284845
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis.
Daskivich TJ; Lai J; Dick AW; Setodji CM; Hanley JM; Litwin MS; Saigal C;
Cancer; 2014 Aug; 120(16):2432-9. PubMed ID: 24824511
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
[TBL] [Abstract][Full Text] [Related]
7. Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer.
Dell'Oglio P; Boehm K; Trudeau V; Tian Z; Larcher A; Leyh-Bannurah SR; Moschini M; Capitanio U; Shariat SF; Briganti A; Montorsi F; Saad F; Karakiewicz PI
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1037-1045. PubMed ID: 27478167
[TBL] [Abstract][Full Text] [Related]
8. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer.
Daskivich TJ; Fan KH; Koyama T; Albertsen PC; Goodman M; Hamilton AS; Hoffman RM; Stanford JL; Stroup AM; Litwin MS; Penson DF
Ann Intern Med; 2013 May; 158(10):709-17. PubMed ID: 23689764
[TBL] [Abstract][Full Text] [Related]
9. Competing Causes of Death in Older Adults with Thyroid Cancer.
Papaleontiou M; Norton EC; Reyes-Gastelum D; Banerjee M; Haymart MR
Thyroid; 2021 Sep; 31(9):1359-1365. PubMed ID: 33764188
[No Abstract] [Full Text] [Related]
10. Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer.
Daskivich TJ; Lai J; Dick AW; Setodji CM; Hanley JM; Litwin MS; Saigal C;
Cancer; 2014 Dec; 120(23):3642-50. PubMed ID: 25042117
[TBL] [Abstract][Full Text] [Related]
11. Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer.
Daskivich TJ; Kwan L; Dash A; Greenfield S; Litwin MS
Eur Urol; 2014 Dec; 66(6):1002-9. PubMed ID: 24924554
[TBL] [Abstract][Full Text] [Related]
12. Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study.
Abdollah F; Sun M; Schmitges J; Thuret R; Tian Z; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):95-103. PubMed ID: 22330991
[TBL] [Abstract][Full Text] [Related]
13. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
[TBL] [Abstract][Full Text] [Related]
14. Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.
Tendulkar RD; Hunter GK; Reddy CA; Stephans KL; Ciezki JP; Abdel-Wahab M; Stephenson AJ; Klein EA; Mahadevan A; Kupelian PA
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):94-9. PubMed ID: 23920389
[TBL] [Abstract][Full Text] [Related]
15. Causes of death and relative survival of older women after a breast cancer diagnosis.
Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
[TBL] [Abstract][Full Text] [Related]
16. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
Sweat SD; Bergstralh EJ; Slezak J; Blute ML; Zincke H
J Urol; 2002 Aug; 168(2):525-9. PubMed ID: 12131302
[TBL] [Abstract][Full Text] [Related]
17. How socioeconomic and clinical factors impact prostate-cancer-specific and other-cause mortality in prostate cancer stratified by clinical stage: Competing-risk analysis.
He H; Han D; Xu F; Lyu J
Prostate; 2022 Mar; 82(4):415-424. PubMed ID: 34927741
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of localized prostate cancer following conservative management.
Lu-Yao GL; Albertsen PC; Moore DF; Shih W; Lin Y; DiPaola RS; Barry MJ; Zietman A; O'Leary M; Walker-Corkery E; Yao SL
JAMA; 2009 Sep; 302(11):1202-9. PubMed ID: 19755699
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
Cooperberg MR; Broering JM; Carroll PR
J Natl Cancer Inst; 2009 Jun; 101(12):878-87. PubMed ID: 19509351
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years.
Huang H; Muscatelli S; Naslund M; Badiyan SN; Kaiser A; Siddiqui MM
J Urol; 2019 Jan; 201(1):120-128. PubMed ID: 30059685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
